SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045018
Filing Date
2019-08-09
Accepted
2019-08-09 06:52:14
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10377_110q.htm 10-Q 983319
2 EX-31.1 a19-10377_1ex31d1.htm EX-31.1 10915
3 EX-31.2 a19-10377_1ex31d2.htm EX-31.2 12168
4 EX-32.1 a19-10377_1ex32d1.htm EX-32.1 16212
  Complete submission text file 0001104659-19-045018.txt   5181874

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lptx-20190630.xml EX-101.INS 1230008
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lptx-20190630.xsd EX-101.SCH 42940
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lptx-20190630_cal.xml EX-101.CAL 39428
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lptx-20190630_def.xml EX-101.DEF 129933
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT lptx-20190630_lab.xml EX-101.LAB 374533
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lptx-20190630_pre.xml EX-101.PRE 274951
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 191011272
SIC: 2834 Pharmaceutical Preparations